Know Cancer

or
forgot password

    • cancer clinical trials in hazleton, PA

    • Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Cancer
    Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Breast Cancer, Cancer Survivor, Hot Flashes
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Breast Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Melanoma (Skin)
    Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Recurrent Adult Acute Lymphoblastic Leukemia
    Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Lymphoma
    Methylphenidate in Treating Patients With Fatigue Caused by Cancer
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Breast Cancer
    Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Pancreatic Cancer
    Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Brain and Central Nervous System Tumors
    Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
    Geisinger South Wilkes Barre-Hazelton Cancer Center
    Hazleton, Pennsylvania 18201
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Pregabalin in Treating Women With Hot Flashes
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Breast Cancer, Hot Flashes
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
    Geisinger Hazleton Cancer Center
    Hazleton, Pennsylvania 18201
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Ovarian Clear Cell Cystadenocarcinoma, Recurrent Ovarian Epithelial Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Light Chain Deposition Disease, Primary Systemic Amyloidosis
    Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
    Geisinger Medical Center-Cancer Center Hazelton
    Hazleton, Pennsylvania 18201
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma